Ocs linked to modestly lower cancer risk, but . . .

Article

Taking oral contraceptive pills may reduce the overal risk of developing certain types of cancer.

Taking oral contraceptive pills may reduce the overall risk of developing certain types of cancer, according to the results of a study published online Sept. 11 in BMJ.

Philip C. Hannaford, MD, of the University of Aberdeen in Scotland, and colleagues investigated the relationship between OCs and the risk of cancer, analyzing data spanning 36 years from a British study that recruited over 46,000 women.

Women who had used OCs had a 3% to 12% reduction in the risk of developing any cancer compared with those who had never used them. However, women who had taken the Pill for 8 or more years had an increased risk of developing cancer, particularly cervical and central nervous system cancer, but had a reduced risk of ovarian cancer.

Hannaford PC, Selvaraj S, Elliott AM, et al. Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study. BMJ. 2007;335:651-654.

Recent Videos
First US national HPV conference highlights advances in cancer prevention | Image Credit: uchealth.com.
Mitchell Creinin, MD, reports estetrol pill eases menstrual symptoms | Image Credit: health.ucdavis.edu
1 expert is featured in this series.
Susanna Mitro, PhD, reveals ethnic disparities in uterine fibroid diagnosis | Image Credit: divisionofresearch.kaiserpermanente.org.
Shayna Mancuso, DO, highlights the real impact of menopause | Image Credit: linkedin.com.
Jihong Liu, ScD, explains how to improve perinatal outcomes in COVID patients | Image Credit: sc.edu.
1 expert is featured in this series.
Jihong Liu, ScD, highlights adverse perinatal outcomes linked to the COVID pandemic | Image Credit: sc.edu.
Experts highlight infant health benefits from minor diet changes in pregnancy | Image Credit: ohsu.edu.
Connie Stark, RNC, PNC, provides fertility preservation insights for endometriosis patients | Image Credit: linkedin.com.
Related Content
© 2025 MJH Life Sciences

All rights reserved.